Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1776
DELISTED
Emcore Corp
EMKR
| $4.03M | ﹤0.01% |
126,844
+10,617
| +9% | +$300K |
2014 Q4
22 quarters
|
|
1777
Preformed Line Products
PLPC
$1.84B
| $4.03M | ﹤0.01% |
80,600
+100
| +0.1% | +$4.87K |
2015 Q2
20 quarters
|
|
1778
Dine Brands
DIN
$395M
| $4.03M | ﹤0.01% |
95,600
-656,300
| -87% | -$26.5M |
2017 Q4
10 quarters
|
|
1779
First Business Financial Services
FBIZ
$580M
| $4.02M | ﹤0.01% |
244,365
-32,315
| -12% | -$505K |
2014 Q1
25 quarters
|
|
1780
Comfort Systems
FIX
$54.3B
| $4.02M | ﹤0.01% |
98,600
+77,000
| +356% | +$2.74M |
2020 Q1
1 quarter
|
|
1781
Alico
ALCO
$283M
| $4.01M | ﹤0.01% |
128,696
+10,191
| +9% | +$303K |
2013 Q2
28 quarters
|
|
1782
Hanover Insurance
THG
$7.88B
| $4M | ﹤0.01% |
39,500
-26,300
| -40% | -$2.58M |
2020 Q1
1 quarter
|
|
|
GLOG
1783
DELISTED
GASLOG LTD
GLOG
| $4M | ﹤0.01% |
1,424,599
+206,800
| +17% | +$754K |
2016 Q4
14 quarters
|
|
1784
Champion Homes
SKY
$4.12B
| $4M | ﹤0.01% |
164,220
-68,500
| -29% | -$1.43M |
2019 Q3
3 quarters
|
|
1785
El Pollo Loco
LOCO
$479M
| $3.98M | ﹤0.01% |
269,600
+73,500
| +37% | +$943K |
2017 Q2
12 quarters
|
|
1786
Chiron Real Estate Inc
XRN
$414M
| $3.98M | ﹤0.01% |
70,190
-39,120
| -36% | -$2.12M |
2017 Q4
10 quarters
|
|
1787
Civista Bancshares
CIVB
$550M
| $3.97M | ﹤0.01% |
257,902
-67,389
| -21% | -$980K |
2013 Q2
28 quarters
|
|
1788
Darling Ingredients
DAR
$9.84B
| $3.97M | ﹤0.01% |
161,300
-325,400
| -67% | -$7.09M |
2020 Q1
1 quarter
|
|
1789
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.2B
| $3.96M | ﹤0.01% |
134,800
+10,540
| +8% | +$309K |
2020 Q1
1 quarter
|
|
1790
Resources Connection
RGP
$94.7M
| $3.95M | ﹤0.01% |
330,142
+56,642
| +21% | +$614K |
2014 Q3
23 quarters
|
|
1791
EnerSys
ENS
$6.26B
| $3.95M | ﹤0.01% |
+61,300
| New | +$3.61M |
2020 Q2
0 quarters
|
|
1792
Northrim BanCorp
NRIM
$536M
| $3.94M | ﹤0.01% |
627,600
-29,600
| -5% | -$172K |
2013 Q2
28 quarters
|
|
|
AIU
1793
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
| $3.93M | ﹤0.01% |
8,009
+1,903
| +31% | +$1.01M |
2018 Q4
6 quarters
|
|
1794
United-Guardian
UG
$32M
| $3.92M | ﹤0.01% |
264,600
-2,670
| -1% | -$39.9K |
2013 Q2
28 quarters
|
|
1795
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.04B
| $3.91M | ﹤0.01% |
+147,300
| New | +$3.84M |
2020 Q2
0 quarters
|
|
1796
DELISTED
ODP
ODP
| $3.9M | ﹤0.01% |
+165,902
| New | +$3.62M |
2020 Q2
0 quarters
|
|
1797
Eastern Company
EML
$146M
| $3.89M | ﹤0.01% |
217,899
-501
| -0.2% | -$9.16K |
2013 Q2
28 quarters
|
|
1798
Blue Owl Capital
OBDC
$4.98B
| $3.89M | ﹤0.01% |
315,800
+217,200
| +220% | +$2.68M |
2020 Q1
1 quarter
|
|
1799
Sabre
SABR
$718M
| $3.89M | ﹤0.01% |
482,700
-2,775,400
| -85% | -$19.7M |
2019 Q3
3 quarters
|
|
1800
Viomi Technology
VIOT
$99.6M
| $3.88M | ﹤0.01% |
731,532
+288,700
| +65% | +$1.58M |
2019 Q3
3 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 583 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.